In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...

The shares of NECC rose as much as 14.09% to Rs 23.72 apiece. It pared gains to trade 9.52% higher at Rs 22.77 apiece, as of ...

The company may file for an IPO as soon as the first quarter of fiscal 2026, according to people familiar with the matter.

With Mar. 29 (Saturday) and Mar. 30 (Sunday) already holidays, traders will get an extended break as the markets are ...

Blue Star expects to sell 15 lakh units of ACs this year — a 50% growth over previous year — driven by robust summer season ...

Goldman Sachs lowered revenue growth forecast for Indian IT service companies significantly because of macroeconomic ...

Generic pharmaceutical companies like Zydus Lifesciences Ltd., Dr. Reddy’s Laboratories Ltd., and Lupin Ltd., which rely ...

Dr. Agarwal's Health Care shares are trading at a significant premium valuation, compared to peers, Jefferies said.

Aditya Arora, from Adlytick.in recommends buying Adani Power, the stock with the highest upside of the lot. With a target ...

Shree Cement is expected to benefit from better cement realisations in its core markets, Nomura said in its note.

Trent and BEL led Nifty 50 surprises in FY25, while IndusInd Bank and Tata Motors were among the biggest disappointments.

ABB India, PB Fintech, Info Edge, and Dr. Agarwal's Eye Hospital are some of the other stocks on analysts' radar.